APIMEDS PHARMACEUTICALS US INC (APUS)
NYSE MKTHealth CareBiotechnologySnapshot 2026-09-04
$2.42-3.59%
Close 2026-09-04 · 1-day change
NYSE MKTHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · APUS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Operating Expenses & Income | |||||
| R&D Expenses | — | 1.6 | — | 0.1 | — |
| Operating Income | (27.3) | (11.9) | (1.3) | (0.7) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 0.3 | 0.1 | — | — |
| Interest & Investment Income | 0.1 | 0.1 | 0.0 | 0.0 | — |
| Other Non-Operating Income / Expenses | (30.8) | 5.9 | (0.1) | (0.0) | — |
| Net Income | |||||
| Net Income | (58.2) | (6.0) | (1.4) | (0.8) | — |
| Per Share | |||||
| Basic EPS | (33.95) | (0.55) | (0.18) | (0.17) | — |
| Diluted EPS | (33.95) | (0.55) | (0.18) | (0.17) | — |
| Basic Weighted Avg Shares | 1.7 | 10.9 | 7.9 | 4.6 | — |
| Diluted Weighted Avg Shares | 1.7 | 10.9 | — | — | — |
| Supplemental | |||||
| EBIT | (27.3) | (11.9) | (1.3) | (0.7) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.